Rhythm Pharmaceuticals, a small biotech stock, has seen significant growth and has multiple catalysts on the horizon. Despite facing risks like pipeline setbacks, the company’s potential for further rise is promising. Another growth stock, Rhythm, has outperformed Google and Nvidia, with a price target reflecting a 40% upside. With positive sales figures and upcoming FDA decisions, Rhythm Pharmaceuticals is a stock to watch.

Read more at Nasdaq: This High-Flying Growth Stock Is Hiding in Plain Sight